XTANT MEDICAL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.20 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-11-14
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-09-30 was $1.20.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $0.65, a 18.18% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $0.55.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2014-03-31 was $0.00.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2013 was $0.53, a 48.54% decline from fiscal 2012.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2012 was $1.03, a 25.90% decline from fiscal 2011.
- XTANT MEDICAL HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2011 was $1.39.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|---|
| 2023-09-30 | $1.20 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $0.61 10-Q · filed 2023-08-01 | ||||
| 2023-03-31 | $0.65 10-Q · filed 2023-05-04 | ||||
| 2022-06-30 | $0.55 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | $0.55 10-Q · filed 2022-05-05 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | ||||
| 2015-06-30 | $2.81 10-Q · filed 2016-08-10 | ||||
| 2014-06-30 | $5.00 10-Q · filed 2014-08-14 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $0.53 10-K · filed 2014-03-27 | ||||
| 2013-09-30 | $0.53 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $5.00 10-Q · filed 2014-08-14 | $0.50 10-Q · filed 2013-08-13 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $1.03 10-K · filed 2014-03-27 | ||||
| 2012-09-30 | $1.19 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | $1.05 10-Q · filed 2013-08-13 | ||||
| 2012-03-31 | $1.38 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $1.39 10-K · filed 2013-03-27 | ||||
| 2011-09-30 | $1.35 10-Q · filed 2012-11-08 | ||||
| 2011-06-30 | $1.91 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |